James Kenigsberg, a director at American Public Education Inc. (NASDAQ:APEI), executed a sale of 600 shares of the company's common stock on November 13, according to a recent SEC filing. The shares were sold at a price of $19.00 each, amounting to a total transaction value of $11,400. Following this sale, Kenigsberg holds 27,032 shares in the company. The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 8, 2024.
In other recent news, American Public Education Inc. (APEI) has reported a steady growth in its Q3 earnings, with a focus on healthcare education. The company witnessed a 1.5% year-over-year increase in revenue, reaching $153 million, marking its fourth consecutive quarter of growth. The adjusted EBITDA for the quarter exceeded guidance at $12.9 million, and net income reached $731,000, or $0.04 per diluted share, which was at the high end of the company's guidance.
APEI's strategic focus on nursing and healthcare programs has led to significant enrollment growth, particularly in online programs. The company has also projected an increase in full-year revenue for 2024, with an expected growth of 3% to 4% compared to 2023. Adjusted EBITDA is also expected to grow by 7% to 12% from 2023.
Despite a rise in total expenses by $3.5 million in Q3 2024, mainly due to higher compensation and professional fees, APEI maintains a strong financial position with $162.2 million in cash and equivalents, with no borrowings under the revolving credit facility. These recent developments underscore APEI's commitment to enhancing value for students and stakeholders.
InvestingPro Insights
While James Kenigsberg's recent sale of American Public Education Inc. (NASDAQ:APEI) shares might raise questions, a closer look at the company's financials and market performance reveals a more nuanced picture. According to InvestingPro data, APEI has shown strong market performance, with a remarkable 200% price total return over the past year and a 91.19% return year-to-date. This impressive growth suggests that despite the director's sale, the company's overall trajectory remains positive.
InvestingPro Tips highlight that APEI is trading at a low P/E ratio relative to its near-term earnings growth, with a PEG ratio of 0.28 for the last twelve months as of Q3 2024. This indicates that the stock may be undervalued considering its growth prospects. Additionally, the company operates with a moderate level of debt and has liquid assets exceeding short-term obligations, pointing to a solid financial position.
It's worth noting that while APEI's P/E ratio of 31.81 might seem high at first glance, the company's expected net income growth and profitability outlook could justify this valuation. Analysts predict that APEI will be profitable this year, which aligns with the company's recent financial performance.
For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for APEI, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.